A researcher-initiated and conducted multicenter, randomized controlled trial aimed at evaluating the efficacy and safety of ultra-early statin therapy in the treatment of acute aneurysmal subarachnoid hemorrhage (aSAH).
Male or female; Aged ≥18 years
Signs and symptoms presumed aneurysmal subarachnoid hemorrhage, confirmed by radiological evidence
Treatment within 6 h after symptom onset
Treatment with statin prior SAH
Non-aSAH (e.g. traumatic subarachnoid hemorrhage, arteriovenous malformation)
Treatment > 6 h after symptom onset
Allergy to statin medications or presence of severe adverse reactions such as abnormal liver function or rhabdomyolysis
The George Institute
Lead sponsor
Tianjin Medical University General Hospital
Collaborator